International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network.
Source:http://linkedlifedata.com/resource/pubmed/id/9641689
Circulation
1998
Jun
23
97
24
2386-95
